Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: A prospective cohort study (JDDM 20)

Diabetic Medicine

Volumn 28, Issue 10, 2011, Pages 1221-1228

  Yokoyama, H ^a   Matsushima, M ^b   Kawai, K ^c   Hirao, K ^d   Oishi, M ^e   Sugimoto, H ^f   Takeda, H ^g   Minami, M ^h   Kobayashi, M ⁱ   Sone, H ^j  

^a Jiyugaoka Medical Clinic   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kawai Clinic   (Japan)

^d HEC Science Clinic   (Japan)

^e Oishi Clinic   (Japan)

^f Sugimoto Clinic   (Japan)

^g Takeda Clinic   (Japan)

^h Minami Masae Clinic   (Japan)

ⁱ UNIVERSITY OF TOYAMA   (Japan)

^j UNIVERSITY OF TSUKUBA   (Japan)

more..

Author keywords

Cardiovascular events; Cohort; Large scale study; Primary care settings; Type 2 diabetes

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY;

ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; STROKE;

EID: 80052972211     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03347.x     Document Type: Article

References (30)

1. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner BA. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141-1147.
2. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type2 diabetes (UKPDS35): prospective observational study. Br Med J 2000; 321: 405-412.
3. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type2 diabetes. N Engl J Med 2003; 348: 383-393.
4. Reaven PD, Moritz TE, Schwenke DC, Anderson RJ, Criqui M, Detrano R et al. Veterans Affairs Diabetes Trial. Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes 2009; 58: 2642-2648.
5. Deferrari G, Ravera M, Deferrari L, Vettoretti S, Ratto E, Parodi D. Renal and cardiovascular protection in type2 diabetes mellitus: angiotensinII receptor blockers. J Am Soc Nephrol 2002; 13: S224-S229.
6. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ et al. CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696.
7. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA et al. ACCORD Study Group. Effects of intensive blood-pressure control in type2 diabetes mellitus. N Engl J Med 2010; 362: 1575-1585.
8. Yokoyama H, Kawai K, Oishi M, Sone H on behalf of Japan Diabetes Data Management Study Group. Familial predisposition to cardiovascular risk and disease contributes to cardiovascular risk and disease interacting with other cardiovascular risk factors in diabetes-implication for common soil (JDDM14). Atherosclerosis 2008; 201: 332-338.
9. Yokoyama H, Oishi M, Kawai K, Sone H on behalf of the Japan Diabetes Clinical Data Management Study Group. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type2 diabetes: JDDM study 16. Diabet Med 2008; 25: 1426-1432.
10. Kobayashi M, Yamazaki K, Hirao K, Oishi M, Kanatsuka A, Yamauchi M et al. Japan Diabetes Clinical Data Management Study Group. The status of diabetes control and antidiabetic drug therapy in Japan-a cross-sectional survey of 17000 patients with diabetes mellitus (JDDM1). Diabetes Res Clin Pract 2006; 73: 198-204.
11. Guideline Committee of the Japan Diabetes Society. Japan Diabetes Society Guidelines for the Management of Diabetes Based on Scientific Evidences. Tokyo: Japan Diabetes Society, 2004.
12. Braunwald E. Unstable angina and chronic coronary disease. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Heart Disease, 6th edn. Chapters 36 and 37. Tokyo: Saunders, 2001: 123.
13. Avogaro A, Giorda C, Maggini M, Mannucci E, Raschetti R, Lombardo F et al. Diabetes and Informatics Study Group, Association of Clinical Diabetologists, Istituto Superiore di Sanità. Incidence of coronary heart disease in type2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 2007; 30: 1241-1247.
14. Lee CD, Folsom AR, Pankow JS, Brancati FL Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular events in diabetic and non-diabetic adults with or without history of myocardial infarction. Circulation 2004; 109: 855-860.
15. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR et al. FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-1861.
16. Rajamani K, Colman PG, Li LP, Best JD, Voysey M, D'Emden MC et al. FIELD study investigators. Effect of fenofibrate on amputation events in people with type2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial. Lancet 2009; 373: 1740-1741.
17. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: UK Prospective Diabetes Study (UKPDS23). Br Med J 1998; 316: 823-828.
18. Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA et al. UKPDS60: risk of stroke in type2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002; 33: 1776-1781.
19. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type2 diabetes. Diabetes Care 2002; 25: 894-899.
20. Oluwatowoju I, Abu E, Wild SH, Byrne CD. Improvements in glycaemic control and cholesterol concentrations associated with the Quality and Outcomes Framework: a regional 2-year audit of diabetes care in the UK. Diabet Med 2010; 27: 354-359.
21. Sone H, Tanaka S, Iimuro S, Tanaka S, Oida K, Yamasaki Y et al. Japan Diabetes Complications Study Group. Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia 2010; 53: 419-428.
22. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y et al. Cardiovascular disease and risk factors in Asia: a selected review. Circulation 2008; 118: 2702-2709.
23. Iso H. Changes in coronary heart disease risk among Japanese. Circulation 2008; 118: 2725-2759.
24. Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: the Akita-Osaka study. J Am Coll Cardiol. 2008; 52: 71-79.
25. Doi Y, Ninomiya T, Hata J, Fukuhara M, Yonemoto K, Iwase M et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2010; 41: 203-209.
26. Mayo NE, Nadeau L, Daskalopoulou SS, Côté R. The evolution of stroke in Quebec: a 15-year perspective. Neurology 2007; 68: 1122-1127.
27. Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation. 2008; 118: 2672-2678.
28. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type2 diabetes. N Engl J Med 2008; 359: 1577-1589.
29. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type2 diabetes. N Engl J Med 2008; 358: 580-591.
30. Arai K, Hirao K, Matsuba I, Matsuba I, Takai M, Takeda H et al. The status of glycemic control by general practitioners and specialists for diabetes in Japan: a cross-sectional survey of 15652 patients with diabetes mellitus. Diabetes Res Clin Pract 2009; 83: 397-401.